1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodoma

Jiang, Jiewei; Zhao, Pei-Liang; Sigua, Logan H.; Chan, Alice; Schonbrunn, Ernst; Qi, Jun; Georg, Gunda I.

doi:10.1002/ardp.202200288

1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodoma

Journal Article · 01 November 2022 · Arch. Pharm.

DOI:https://doi.org/10.1002/ardp.202200288· OSTI ID:1901119

Jiang, Jiewei; Zhao, Pei-Liang; Sigua, Logan H.; Chan, Alice; Schonbrunn, Ernst; Qi, Jun; Georg, Gunda I.

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; NIH

OSTI ID:: 1901119

Journal Information:: Arch. Pharm., Journal Name: Arch. Pharm. Journal Issue: (11) Vol. 355

Country of Publication:: United States

Language:: ENGLISH

References (52)

The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators Wai, Dorothy C. C.; Szyszka, Taylor N.; Campbell, Amy E. Journal of Biological Chemistry, Vol. 293, Issue 19 https://doi.org/10.1074/jbc.RA117.000678	journal	May 2018
Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2 Salvatori, B.; Iosue, I.; Djodji Damas, N. Genes & Cancer, Vol. 2, Issue 5 https://doi.org/10.1177/1947601911416357	journal	May 2011
A Bead-Based Proximity Assay for BRD4 Ligand Discovery: Proximity Assay for BRD4 Ligand Discovery Roberts, Justin M.; Bradner, James E. Current Protocols in Chemical Biology, Vol. 7, Issue 4 https://doi.org/10.1002/9780470559277.ch150024	journal	November 2015
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site Liu, Zhiqing; Li, Yi; Chen, Haiying Journal of Medicinal Chemistry, Vol. 65, Issue 3 https://doi.org/10.1021/acs.jmedchem.1c01851	journal	January 2022
Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors Karim, Rezaul Md; Bikowitz, Melissa J.; Chan, Alice Journal of Medicinal Chemistry, Vol. 64, Issue 21 https://doi.org/10.1021/acs.jmedchem.1c01096	journal	October 2021
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria Cell, Vol. 149, Issue 1 https://doi.org/10.1016/j.cell.2012.02.013	journal	March 2012
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors Piha-Paul, Sarina A.; Hann, Christine L.; French, Christopher A. JNCI Cancer Spectrum, Vol. 4, Issue 2 https://doi.org/10.1093/jncics/pkz093	journal	November 2019
Bromodomain: an acetyl-lysine binding domain Zeng, Lei; Zhou, Ming-Ming FEBS Letters, Vol. 513, Issue 1 https://doi.org/10.1016/S0014-5793(01)03309-9	journal	January 2002
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours Ameratunga, Malaka; Braña, Irene; Bono, Petri British Journal of Cancer, Vol. 123, Issue 12 https://doi.org/10.1038/s41416-020-01077-z	journal	September 2020
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Clinical trials for BET inhibitors run ahead of the science Andrieu, Guillaume; Belkina, Anna C.; Denis, Gerald V. Drug Discovery Today: Technologies, Vol. 19 https://doi.org/10.1016/j.ddtec.2016.06.004	journal	March 2016
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains Mirguet, Olivier; Gosmini, Romain; Toum, Jérôme Journal of Medicinal Chemistry, Vol. 56, Issue 19 https://doi.org/10.1021/jm401088k	journal	September 2013
BRDT Inhibitors for Male Contraceptive Drug Discovery: Current Status Miao, Zhenyuan; Guan, Xianghong; Jiang, Jiewei Targeting Protein-Protein Interactions by Small Molecules https://doi.org/10.1007/978-981-13-0773-7_11	book	January 2018
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit Rianjongdee, Francesco; Atkinson, Stephen J.; Chung, Chun-wa Journal of Medicinal Chemistry, Vol. 64, Issue 15 https://doi.org/10.1021/acs.jmedchem.1c00412	journal	July 2021
Plasticity in binding confers selectivity in ligand-induced protein degradation Nowak, Radosław P.; DeAngelo, Stephen L.; Buckley, Dennis Nature Chemical Biology, Vol. 14, Issue 7 https://doi.org/10.1038/s41589-018-0055-y	journal	June 2018
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer Shu, Shaokun; Lin, Charles Y.; He, Housheng Hansen Nature, Vol. 529, Issue 7586 https://doi.org/10.1038/nature16508	journal	January 2016
MolProbity : all-atom structure validation for macromolecular crystallography Chen, Vincent B.; Arendall, W. Bryan; Headd, Jeffrey J. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1 https://doi.org/10.1107/S0907444909042073	journal	December 2009
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition Rathert, Philipp; Roth, Mareike; Neumann, Tobias Nature, Vol. 525, Issue 7570 https://doi.org/10.1038/nature14898	journal	September 2015
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells Nie, Zuqin; Hu, Gangqing; Wei, Gang Cell, Vol. 151, Issue 1 https://doi.org/10.1016/j.cell.2012.08.033	journal	September 2012
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation Gilan, Omer; Rioja, Inmaculada; Knezevic, Kathy Science, Vol. 368, Issue 6489 https://doi.org/10.1126/science.aaz8455	journal	March 2020
Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth Ren, Chunyan; Zhang, Guangtao; Han, Fangbin Proceedings of the National Academy of Sciences, Vol. 115, Issue 31 https://doi.org/10.1073/pnas.1720000115	journal	July 2018
BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen Ayoub, Alex M.; Hawk, Laura M. L.; Herzig, Ryan J. Journal of Medicinal Chemistry, Vol. 60, Issue 12 https://doi.org/10.1021/acs.jmedchem.6b01336	journal	June 2017
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors Lewin, Jeremy; Soria, Jean-Charles; Stathis, Anastasios Journal of Clinical Oncology, Vol. 36, Issue 30 https://doi.org/10.1200/JCO.2018.78.2292	journal	October 2018
Overexpression of c-myc is associated with adverse clinical features and worse overall survival in multiple myeloma Szabo, Agoston Gyula; Gang, Anne Ortved; Pedersen, Mette Ølgod Leukemia & Lymphoma, Vol. 57, Issue 11 https://doi.org/10.1080/10428194.2016.1187275	journal	May 2016
The Conserved 12-Amino Acid Stretch in the Inter-Bromodomain Region of BET Family Proteins Functions as a Nuclear Localization Signal Fukazawa, Hidesuke; Masumi, Atsuko Biological and Pharmaceutical Bulletin, Vol. 35, Issue 11 https://doi.org/10.1248/bpb.b12-00527	journal	January 2012
Design and characterization of bivalent BET inhibitors Tanaka, Minoru; Roberts, Justin M.; Seo, Hyuk-Soo Nature Chemical Biology, Vol. 12, Issue 12 https://doi.org/10.1038/nchembio.2209	journal	October 2016
Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4 Zhang, Qiang; Zeng, Lei; Shen, Chen Structure, Vol. 24, Issue 7 https://doi.org/10.1016/j.str.2016.04.019	journal	July 2016
Importance of Purity Evaluation and the Potential of Quantitative ¹ H NMR as a Purity Assay: Miniperspective Pauli, Guido F.; Chen, Shao-Nong; Simmler, Charlotte Journal of Medicinal Chemistry, Vol. 57, Issue 22 https://doi.org/10.1021/jm500734a	journal	October 2014
Expression of BET genes in testis of men with different spermatogenic impairments Barda, Shimi; Paz, Gedalia; Yogev, Leah Fertility and Sterility, Vol. 97, Issue 1 https://doi.org/10.1016/j.fertnstert.2011.10.010	journal	January 2012
Brd4 and JMJD6-Associated Anti-Pause Enhancers in Regulation of Transcriptional Pause Release Liu, Wen; Ma, Qi; Wong, Kaki Cell, Vol. 155, Issue 7 https://doi.org/10.1016/j.cell.2013.10.056	journal	December 2013
The first bromodomain of the testis-specific double bromodomain protein Brdt is required for chromocenter organization that is modulated by genetic background Berkovits, Binyamin D.; Wolgemuth, Debra J. Developmental Biology, Vol. 360, Issue 2 https://doi.org/10.1016/j.ydbio.2011.10.005	journal	December 2011
AMPK–ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells Jang, Ji Eun; Eom, Ju-In; Jeung, Hoi-Kyung Clinical Cancer Research, Vol. 23, Issue 11 https://doi.org/10.1158/1078-0432.CCR-16-1903	journal	May 2017
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer Faivre, Emily J.; McDaniel, Keith F.; Albert, Daniel H. Nature, Vol. 578, Issue 7794 https://doi.org/10.1038/s41586-020-1930-8	journal	January 2020
Correction to Importance of Purity Evaluation and the Potential of Quantitative ¹H NMR as a Purity Assay Pauli, Guido F.; Chen, Shao-Nong; Simmler, Charlotte Journal of Medicinal Chemistry, Vol. 58, Issue 22 https://doi.org/10.1021/acs.jmedchem.5b01667	journal	November 2015
Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains Lambert, Jean-Philippe; Picaud, Sarah; Fujisawa, Takao Molecular Cell, Vol. 73, Issue 3 https://doi.org/10.1016/j.molcel.2018.11.006	journal	February 2019
XDS Kabsch, Wolfgang Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2 https://doi.org/10.1107/S0907444909047337	journal	January 2010
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc Delmore, Jake E.; Issa, Ghayas C.; Lemieux, Madeleine E. Cell, Vol. 146, Issue 6 https://doi.org/10.1016/j.cell.2011.08.017	journal	September 2011
phenix.model_vs_data : a high-level tool for the calculation of crystallographic model and data statistics Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Chen, Vincent B. Journal of Applied Crystallography, Vol. 43, Issue 4 https://doi.org/10.1107/S0021889810015608	journal	May 2010
First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity Postel-Vinay, Sophie; Herbschleb, Karin; Massard, Christophe European Journal of Cancer, Vol. 109 https://doi.org/10.1016/j.ejca.2018.12.020	journal	March 2019
4-Methyl-1,2,3-Triazoles as N -Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity Cui, Huarui; Carlson, Angela S.; Schleiff, Mary A. Journal of Medicinal Chemistry, Vol. 64, Issue 14 https://doi.org/10.1021/acs.jmedchem.1c00933	journal	July 2021
Discovery of N -(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1 H -pyrrolo[2,3- c ]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor McDaniel, Keith F.; Wang, Le; Soltwedel, Todd Journal of Medicinal Chemistry, Vol. 60, Issue 20 https://doi.org/10.1021/acs.jmedchem.7b00746	journal	October 2017
The Bromodomain Protein Brd4 Is a Positive Regulatory Component of P-TEFb and Stimulates RNA Polymerase II-Dependent Transcription Jang, Moon Kyoo; Mochizuki, Kazuki; Zhou, Meisheng Molecular Cell, Vol. 19, Issue 4 https://doi.org/10.1016/j.molcel.2005.06.027	journal	August 2005
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation Sakamoto, K. M.; Kim, K. B.; Kumagai, A. Proceedings of the National Academy of Sciences, Vol. 98, Issue 15 https://doi.org/10.1073/pnas.141230798	journal	July 2001
The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3 Rahman, S.; Sowa, M. E.; Ottinger, M. Molecular and Cellular Biology, Vol. 31, Issue 13 https://doi.org/10.1128/MCB.01341-10	journal	May 2011
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors Seal, Jonathan T.; Atkinson, Stephen J.; Bamborough, Paul Journal of Medicinal Chemistry, Vol. 64, Issue 15 https://doi.org/10.1021/acs.jmedchem.1c00365	journal	July 2021
Molecular complexes at a glance: automated generation of two-dimensional complex diagrams Stierand, K.; Maass, P. C.; Rarey, M. Bioinformatics, Vol. 22, Issue 14 https://doi.org/10.1093/bioinformatics/btl150	journal	April 2006
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors Lucas, Simon C. C.; Atkinson, Stephen J.; Chung, Chun-wa Journal of Medicinal Chemistry, Vol. 64, Issue 15 https://doi.org/10.1021/acs.jmedchem.1c00344	journal	July 2021
Small-Molecule Inhibition of BRDT for Male Contraception Matzuk, Martin M.; McKeown, Michael R.; Filippakopoulos, Panagis Cell, Vol. 150, Issue 4 https://doi.org/10.1016/j.cell.2012.06.045	journal	August 2012
Selective inhibition of BET bromodomains Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah Nature, Vol. 468, Issue 7327 https://doi.org/10.1038/nature09504	journal	September 2010
Discovery and characterization of bromodomain 2–specific inhibitors of BRDT Yu, Zhifeng; Ku, Angela F.; Anglin, Justin L. Proceedings of the National Academy of Sciences, Vol. 118, Issue 9 https://doi.org/10.1073/pnas.2021102118	journal	February 2021
The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation Shang, E.; Nickerson, H. D.; Wen, D. Development, Vol. 134, Issue 19 https://doi.org/10.1242/dev.004481	journal	October 2007

Similar Records

Synthesis and characterization of ester and amide derivatives of titanium(IV) carboxymethylphosphonate

Journal Article · 2013 · Journal of Solid State Chemistry · OSTI ID:22306319

Ductile gas barrier poly(ester?amide)s derived from glycolide

Journal Article · 2022 · Polym. Chem. - UK · OSTI ID:1876076

Ductile gas barrier poly(ester?amide)s derived from glycolide

Journal Article · 2022 · Polym. Chem. - UK · OSTI ID:1875161

1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodoma

Citation Formats

References (52)

Similar Records

Related Subjects